| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Jounce Therapeutics, Inc. | Director | Common Stock | 1 | $2 | $1.85 | 03 May 2023 | Direct |
| Jounce Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 0 | 03 May 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| JNCE | Jounce Therapeutics, Inc. | 03 May 2023 | 11 | $0 | 4 | Director | 04 May 2023, 07:44 |
| JNCE | Jounce Therapeutics, Inc. | 04 Apr 2023 | 1 | -$72,572 | 4 | Director | 06 Apr 2023, 16:37 |
| JNCE | Jounce Therapeutics, Inc. | 09 Jan 2023 | 2 | -$50,075 | 4 | CEO and President, Director | 11 Jan 2023, 19:32 |
| JNCE | Jounce Therapeutics, Inc. | 01 Feb 2022 | 2 | $0 | 4 | CEO and President, Director | 03 Feb 2022, 18:37 |
| JNCE | Jounce Therapeutics, Inc. | 07 Jan 2022 | 2 | -$256,696 | 4 | CEO and President, Director | 11 Jan 2022, 19:57 |